Bio-Techne (TECH) Interest & Investment Income (2009 - 2026)
Bio-Techne's (TECH) quarterly Interest & Investment Income came in at $981000.0 in Q1 2026, down 4.39% year-on-year from $1.0 million in Q1 2025, and up 9.36% quarter-over-quarter from $897000.0 in Q4 2025.
Bio-Techne (TECH) Interest & Investment Income (2009 - 2026) Analysis & Trends
Bio-Techne's Interest & Investment Income history runs 18 years deep, the most recent figure standing at $981000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 4.39% year-over-year to $981000.0 in Q1 2026; TTM through Mar 2026 was $3.4 million, a 18.34% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, up 16.94% from the prior year.
- Interest & Investment Income advanced to $981000.0 in Q1 2026 per TECH's latest filing, from $897000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.3 million in Q4 2024 and bottomed at $168000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $905000.0 (2024), against an average of $813117.6.
- Across the five-year window, Interest & Investment Income soared 479.76% in 2023 and slumped 35.36% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $968000.0 in 2022, then fell by 15.7% to $816000.0 in 2023, then soared by 65.2% to $1.3 million in 2024, then tumbled by 33.46% to $897000.0 in 2025, then advanced by 9.36% to $981000.0 in 2026.
- Per Business Quant, the three latest TECH Interest & Investment Income figures stand at $981000.0 (Q1 2026), $897000.0 (Q4 2025), and $971000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Bio-Techne | 11.20 Bn | 10.99 Bn | 208.29 Mn | 981,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 585,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 926,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | 890,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 974,000.00 |
| Dec 31, 2022 | 968,000.00 |
| Sep 30, 2022 | 433,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 167,000.00 |